Serum Vancomycin Levels in Patients Receiving Enteral Vancomycin

Completed

Conditions studied: Clostridium Difficle Colitis, Clostridium Difficle Associated Disease

In brief

The study is based on the hypothesis that decreased creatinine clearance may be associated with detectable vancomycin levels in patients on enteral (oral / vancomycin enemas) vancomyicn for CDAD. The objective of the study is to see whether enteral vancomycin is absorbed through the inflamed GI mucosa in CDAD, and if it is absorbed, does it achieve measurable serum concentration.

Key facts

Study ID

NCT00617227

Run by

Maimonides Medical Center

People needed

100

Starts

2007-10-01

Expected to finish

2010-02-01

Last updated by the study team

2010-02-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients on enteral vancomycin therapy

You may not qualify if…

• Coadministration of intravenous vancomycin therapy,intravenousvancomycin administration in previous10 days.

Where it is running

• Maimonides Medical Center — Brooklyn, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.